Head-to-head · Cost-Efficiency Index
GOAL.MD vs altRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
GOAL.MD
Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Visit GOAL.MDaltRX
Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires.
Visit altRXThe verdict
GOAL.MD takes it, leading the Cost-Efficiency Index 71 to 70. GOAL.MD (goal.md) is a physician-run telehealth weight-loss practice, led by Chief Physician Dr. Michael Mimlitz, MD. altRX still earns a C — Cost-first shoppers who want locking in a flat, same-at-every-dose promotional rate before it expires.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs GOAL.MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | GOAL.MD | altRX |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $199/mo (promotional rate, compounded) | $89/mo (all doses, promotional rate, plus a separate fee, compounded) |
| Tirzepatide / mo | $299/mo (compounded) | $149/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,068 |
| Tirzepatide / yr (modeled) | $3,588 | $1,788 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #81 | #85 |
GOAL.MD
71/100Where the value is
- Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
- Multiple product tiers (standard, micro-dose, combination 'Synergy') for different budgets and needs
- 3-month bundle discount available on the combination product ($547/mo vs. $597/mo single-month)
The tradeoffs
- The widely advertised '$149' price is a first-month-only discount; the standing rate is $199/mo semaglutide and $299/mo tirzepatide — more than double the headline for tirzepatide
- No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
altRX
70/100Where the value is
- Same price at every dose — titrating up does not raise the monthly cost, unlike per-mg-tiered competitors
- No membership fee, no insurance required; price stated to be all-in (consultation, dosing plan, medication, free delivery, clinician support)
- LegitScript certified
The tradeoffs
- The advertised $89/$149 prices are an explicitly time-limited promotion with a live countdown on the page — the standing price is roughly double, and a naive reading of the headline as a stable price would be wrong within about a week of this research
- No compounding pharmacy is individually named, only '503A compounding pharmacies within the altRx network'
Regulatory note: the FDA issued a warning letter to Trinity HealthCare Supply, LLC dba altRx in June 2026. We still list and link to altRX; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.